The ARHGEF6 Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population designed for functional studies of ARHGEF6. This heterogeneous pool of HAP1 cells carries disrupted ARHGEF6 alleles via CRISPR/Cas9-mediated gene disruption, without clonal selection. The polyclonal format maintains genetic diversity while achieving target-gene knockout, suitable for population-level assays and functional screens. It serves as a loss-of-function model to investigate ARHGEF6 roles in signaling and disease.
HAP1 is a near-haploid human fibroblast-like hematopoietic cell line derived from the KBM-7 chronic myeloid leukemia line. Its haploid karyotype enables straightforward knockout generation, as single-allele disruption yields a loss-of-function phenotype. HAP1 cells grow adherently, proliferate rapidly, and are widely used for genetic studies, including CRISPR screens and pathway analysis. Their fibroblastoid morphology and hematopoietic origin make them an ideal platform for studying actin-dependent processes like adhesion, migration, and cell?Cmatrix interactions.
ARHGEF6 encodes a Rac/Cdc42 guanine nucleotide exchange factor (RhoGEF) that activates Rac1 and Cdc42 GTPases. Upstream signals from integrin engagement, growth factor receptors, and PI3K stimulate ARHGEF6 to promote nucleotide exchange on Rac1/Cdc42. Active Rac1 and Cdc42 then trigger PAK kinases (PAK1, PAK2, PAK3), which phosphorylate LIMK and cofilin, ultimately enhancing actin polymerization. ARHGEF6 interacts with PAK1?C3, GIT1, and ??-PIX, forming a complex that coordinates GTPase signaling and cytoskeletal reorganization. Pathway components including Arp2/3, WAVE, and actin drive lamellipodia formation, membrane ruffling, and focal adhesion dynamics.
In HAP1 cells, ARHGEF6 disruption provides a clean genetic background to dissect Rac1/Cdc42-dependent actin remodeling. The near-haploid genome ensures that knockout phenotypes directly reflect ARHGEF6 loss-of-function, minimizing redundancy. This model allows systematic evaluation of how ARHGEF6 signaling affects cell migration, adhesion, and morphology in a fibroblast-like hematopoietic context. Given ARHGEF6’s involvement in immune cell function and cancer metastasis, HAP1 ARHGEF6 knockout cells are valuable for examining mechanisms of cell motility and invasion, and for validating chemical probes or genetic interactions within the Rho GTPase pathway.
This polyclonal knockout population is amenable to diverse functional assays, including Western blotting to verify ARHGEF6 depletion, GTPase activation assays to assess Rac1 and Cdc42 activity, and phalloidin staining to visualize F-actin. Migration and adhesion assays, combined with immunofluorescence and live imaging, allow quantitative analysis of cytoskeletal dynamics. The model supports drug target validation in cancer metastasis and neurodevelopmental disorders, where ARHGEF6 dysfunction is implicated. For further details, contact Ascent Research.
